News
Biden Inauguration
---
Live Stream
Timestamps in video description
Research / Recap / Additional Video
I bought VIH yesterday @ 14.92, yes yes, another SPAC.. BUT it's not an EV SPAC lol it's the company that will be taking BAKKT public! This is the exchange that many of the big players use to invest into crypto. So if you guys also want additional crypto exposure this is an interesting play via equites.
Recent Motely Fool article for some further reading: https://www.fool.com/investing/2021/01/19/bakkt-spac-is-a-new-way-to-invest-in-bitcoin-heres/
Former CEO Kelly Loeffler
https://en.wikipedia.org/wiki/Kelly_Loeffler
The fool article isn't too good but this one is quite a nice update, especially on Kelly: https://www.coindesk.com/former-bakkt-ceo-kelly-loeffler-loses-senate-seat
Good VW article here if you guys have time
https://www.wsj.com/articles/how-volkswagens-50-billion-plan-to-beat-tesla-short-circuited-11611073974
"The biggest challenge, said Mr. Hilgenberg, isn’t the technology, it is the mind-set of the people—their reluctance to embrace radical change until circumstances force them to."
“Over the past 20 years the auto industry became more integrators than developers,” said Mr. Hitzinger. “Software is written by suppliers. This was good for a while because it drives down costs but you lose control. That’s what the auto industry has to reverse now, bring in deep technical knowledge. That’s the hard part.”
Change is coming, Mr. Diess wrote on his LinkedIn page, and VW must move faster. “The global transformation of the industry will take roughly 10 years,” he wrote. “With or without Volkswagen.”
---
YxngMoethis is onlycleanbangerz just changed my name lol
---
BTWN Bridgetown holdings
426dfvAlex: backed by billionaires Richard Li and Peter Thiel
https://financefeeds.com/tokopedia-wants-list-route-will-choose/
Watchlist
| INUV [AMEX] |
| Inuvo, Inc. |
| Communication Services | Advertising Agencies | USA |
46% 66mc 88f
No New News..
| Jan-14-21 08:30AM |
GlobeNewswire -6.84%
|
| NDRA [NASD] |
| ENDRA Life Sciences Inc. |
| Healthcare | Diagnostics & Research | USA |
46% 34mc 23f
No New News..
| Jan-13-21 09:00AM | |
| Jan-08-21 09:00AM |
| DARE [NASD] |
| Dare Bioscience, Inc. |
| Healthcare | Biotechnology | USA |
23% 105mc 35f
jan 19th "Not seeing any company specific news"
| Jan-05-21 08:00AM |
| STCN [NASD] |
| Steel Connect, Inc. |
| Industrials | Integrated Freight & Logistics | USA |
70% 92mc 56f
No new news?
| Jan-11-21 08:00AM | |
| Jan-08-21 04:15PM |
Business Wire +10.13%
|
| AUTO [NASD] |
| AutoWeb, Inc. |
| Communication Services | Internet Content & Information | USA |
60% 42mc 10f
No new news?
| Dec-17-20 08:00AM | |
| Nov-26-20 11:36PM |
Insider Monkey
|
| CLBS [NASD] |
| Caladrius Biosciences, Inc. |
| Healthcare | Biotechnology | USA |
130% 32mc 17f
"We are very excited about our CLBS16 program as it represents a potential breakthrough in the treatment of CMD, a condition which afflicts millions of patients in the US alone, many of whom are women. As a result, CMD is a women's health issue of emerging importance as currently there are no products with approved labeling for coronary microvascular dysfunction," said David J. Mazzo, PhD, President and Chief Executive Officer of Caladrius. "The treatment of the first patient in the FREEDOM trial is an important milestone for our Company and the program and we look forward to completing enrollment by the target of year-end 2021. It is especially noteworthy that even during the COVID-19 pandemic, physicians and patients are active in our trial, denoting the seriousness of the disease and underscoring the lack of available effective treatment for CMD."
| Jan-19-21 08:00AM | |
| Jan-06-21 08:30AM |
| APM [NASD] |
| Aptorum Group Limited |
| Healthcare | Biotechnology | United Kingdom |
70% 93mc 9f
Jan 20th - Aptorum Group Limited (NASDAQ:APM, Euronext Paris: APM))))) ) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, announced that the company, through its wholly owned subsidiary, Aptorum International Limited, has received clearance from the Public Health Agency of Canada (Health Canada) regarding the Clinical Trial Application (CTA) to commence a Phase 1 study of ALS-4, an orally administered small molecule drug intended to treat infections caused by Staphylococcus aureus including MRSA.
| Jan-20-21 06:00AM | |
| Jan-16-21 01:23AM |
| OBLN [NASD] |
| Obalon Therapeutics, Inc. |
| Healthcare | Medical Devices | USA |
65% 14mc 8f
January 20, 2021 08:42 AM ET (BZ Newswire) -- M&A
Merger Agreement
On January 19, 2021, Obalon Therapeutics, Inc., a Delaware corporation (“Obalon”), Optimus Merger Sub, Inc., a Delaware corporation, and a direct, wholly owned subsidiary of Obalon (“Merger Sub”), and ReShape Lifesciences, Inc., a Delaware corporation (“ReShape”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). Pursuant to the Merger Agreement, and subject to the satisfaction or waiver of the conditions specified therein, Merger Sub shall be merged with and into ReShape, with ReShape surviving as a wholly owned subsidiary of Obalon. Capitalized terms used herein but not defined shall have the respective meanings assigned to them in the Merger Agreement.
Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull
Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save
Watchlist 👉👉 https://tradejournal.co/post/wednesday-pre-market-top-gainers-382/
